Status report of lipid-lowering trials in diabetes

D. John Betteridge, Helen Colhoun, Jane Armitage

Research output: Contribution to journalArticlepeer-review


The prevention and treatment of coronary heart disease is a major challenge in the overall management of the patient with type 2 diabetes. Diabetic dyslipidaemia is an important risk factor and is open to therapeutic intervention. However, as yet there are no primary or secondary coronary heart disease prevention trials of lipid-lowering therapy reported in diabetic populations. In this review, on-going clinical trials of lipid-lowering therapy in specific diabetic populations will be described.
Original languageEnglish
Pages (from-to)621-626
Number of pages6
JournalCurrent Opinion in Lipidology
Issue number6
Publication statusPublished - 2000


Dive into the research topics of 'Status report of lipid-lowering trials in diabetes'. Together they form a unique fingerprint.

Cite this